Form 4: Arteris CEO Sells Shares to Cover Tax Obligations and Under 10b5-1 Plan
SEC Form 4
Arteris CEO, Charles Janac, sold shares to cover tax liabilities and under a pre-arranged 10b5-1 trading plan.
Summary
- Charles Janac, the President and CEO of Arteris, Inc., sold a total of 56,256 shares of common stock on January 2, 2025.
- 3,128 shares were sold at a price of $11.4133 each to cover tax obligations arising from the release of restricted stock units.
- An additional 50,000 shares were sold at a weighted average price of $10.9799 under a 10b5-1 trading plan adopted on February 27, 2024.
- The sales resulted in a decrease in direct holdings of common stock to 268,520 shares.
- Janac also indirectly owns 9,957,691 shares through Bayview Legacy, LLC and 77,286 shares through the Charles and Lydia Janac Trust.
Sentiment
Score: 5
Explanation: The document reflects routine insider transactions, with no indication of positive or negative sentiment. The sales are part of a pre-arranged plan and tax obligations.
Risks
- Sales by insiders can sometimes be perceived negatively by the market, potentially impacting the stock price.
Industry Context
Insider sales are a common occurrence, especially when executives have stock-based compensation. The use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading.
Comparison to Industry Standards
- The use of 10b5-1 trading plans is a common practice among executives at publicly traded companies, including those in the semiconductor and technology sectors, such as ARM Holdings, Synopsys, and Cadence Design Systems.
- These plans allow executives to sell shares at predetermined times and prices, mitigating the risk of insider trading allegations.
- The reported sales are within the typical range of insider transactions for executives at similar companies.
Stakeholder Impact
- The stock sales may have a minor impact on the share price, but the use of a 10b5-1 plan should mitigate any negative perception.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date the 10b5-1 trading plan was adopted by the Reporting Person. |
| 01/02/2025 | Date of the stock sales. |
| 01/06/2025 | Date of the signature on the SEC Form 4. |
Keywords
Arteris, Charles Janac, insider trading, stock sale, 10b5-1 plan, tax liability, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.